A Novel Diet Approach to Combat Gestational Diabetes
1 other identifier
interventional
32
1 country
1
Brief Summary
There is an urgent need to implement novel diet approaches to combat the increasing rates of gestational diabetes mellitus (GDM). The primary aim of this study is to establish the feasibility of time-restricted eating in pregnancy, to prepare for future larger controlled trials in this research project to determine the efficacy of time-restricted eating in women at risk of GDM. Expectations:
- 1.Women who have an increased risk of GDM will be able to adhere to time reduced eating during pregnancy.
- 2.Time reduced eating will improve short-term glycemic control in pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2018
CompletedFirst Posted
Study publicly available on registry
January 14, 2019
CompletedStudy Start
First participant enrolled
January 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2023
CompletedMarch 16, 2023
March 1, 2023
4.2 years
December 18, 2018
March 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in average time-window for energy intake
Average daily time-window for energy intake will be registered through log books.
Change between baseline (pre-intervention) time-window for energy intake to average time-window for energy intake during the 5-week intervention period
Weekly adherence rates for time restricted eating (TRE)
The number of days per week that the participants are able to adhere to TRE, as calculated as weekly average of days with a time-window ≤ 10 hours
Weekly measures throughout the 5 week period of TRE intervention
Secondary Outcomes (17)
Perceived barriers to the protocol assessed with an unstructured interview
Weekly phone calls to participants in TRE group during the 5-week intervention period and after 6 weeks
Subjective appetite sensations assessed by Visual Analogue Scales
Once weekly throughout 6 weeks, on a weekday.
Change between baseline and post-intervention in fasting glucose
6 weeks
Change between baseline and post-intervention in postprandial glucose
6 weeks
Change between baseline and post-intervention in fasting insulin
6 weeks
- +12 more secondary outcomes
Study Arms (2)
Time restricted eating (TRE)
EXPERIMENTALprolonging the duration of fasting between the last evening meal and the first meal of the next day
control
NO INTERVENTIONStandard care. Will receive a booklet about physical activity recommendations and healthy eating in pregnancy
Interventions
Participants will attend a face-to-face meeting with the researchers at the last day of the first week of data collection (habitual diet and physical activity period) where they will be counselled to consume all food and fluid within a 8-10 h time window of their choice starting no later than 09.00 h for five weeks. During the intervention period, they will be counselled by weekly phone calls to provide encouragement, support and monitoring to improve adherence to the TRE window.
Eligibility Criteria
You may qualify if:
- carrying one singleton live foetus
- in pregnancy week 12-30
- having at least one risk factor for gestational diabetes mellitus (GDM) according to Norwegian guidelines for GDM screening: pre-pregnancy BMI \> 25 kg/m2, GDM in previous pregnancy, primiparae aged \> 25 years, first degree relative with diabetes mellitus, Asian or African ethnicity, previous delivery of new-born \> 4.5 kg
- understand written and spoken Norwegian language
You may not qualify if:
- habitual eating window \< 12 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- St. Olavs Hospitalcollaborator
Study Sites (1)
St Olavs Hospital
Trondheim, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Øystein Risa, phd
Department of circulation and medical imaging, NTNU
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2018
First Posted
January 14, 2019
Study Start
January 18, 2019
Primary Completion
March 13, 2023
Study Completion
March 15, 2023
Last Updated
March 16, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share